Background and objective: Temporal trends of healthcare use in the period before a diagnosis of pulmonary fibrosis are poorly understood. We investigated trends in respiratory symptoms and lower respiratory healthcare resource utilisation (HRU) in the 10 years prior to diagnosis.Methods: We analysed a primary care clinical cohort database (UK Optimum Patient Care Research Database) and assessed patients aged ≥40 years who had an electronically coded diagnosis of pulmonary fibrosis between 2005–2015 and a minimum two years continuous medical records prior to diagnosis. Exclusion criteria consisted of electronic codes for recognised causes of pulmonary fibrosis such as CTD, sarcoidosis or extrinsic allergic alveolitis. Results: Data for 2223 ...
AbstractBackgroundIdiopathic pulmonary fibrosis (IPF) may be complicated by episodes of acute exacer...
Acknowledgments The authors would like to extend their acknowledgement to Dr Dermot Ryan for his cli...
RATIONALE: The level diagnostic likelihood at which physicians prescribe antifibrotic therapy withou...
Background: The early diagnosis of idiopathic pulmonary fibrosis (IPF) has become increasingly impor...
Background: Patterns of health-care use and comorbidities present in patients in the period before d...
OBJECTIVE: To explore the clinical pathways, including signs and symptoms, and symptom progression p...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Introduction: Data on the epidemiology of idiopathic pulmonary fibrosis (IPF) in Sweden are lacking....
BackgroundIdiopathic pulmonary fibrosis (IPF) is a rare, chronic lung disease associated with substa...
Many patients with interstitial lung disease (ILD) develop pulmonary fibrosis, which can lead to red...
SummaryBackgroundPatterns of health-care use and comorbidities present in patients in the period bef...
Many patients with interstitial lung disease (ILD) develop pulmonary fibrosis, which can lead to red...
AbstractBackgroundIdiopathic pulmonary fibrosis (IPF) may be complicated by episodes of acute exacer...
Acknowledgments The authors would like to extend their acknowledgement to Dr Dermot Ryan for his cli...
RATIONALE: The level diagnostic likelihood at which physicians prescribe antifibrotic therapy withou...
Background: The early diagnosis of idiopathic pulmonary fibrosis (IPF) has become increasingly impor...
Background: Patterns of health-care use and comorbidities present in patients in the period before d...
OBJECTIVE: To explore the clinical pathways, including signs and symptoms, and symptom progression p...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variat...
Introduction: Data on the epidemiology of idiopathic pulmonary fibrosis (IPF) in Sweden are lacking....
BackgroundIdiopathic pulmonary fibrosis (IPF) is a rare, chronic lung disease associated with substa...
Many patients with interstitial lung disease (ILD) develop pulmonary fibrosis, which can lead to red...
SummaryBackgroundPatterns of health-care use and comorbidities present in patients in the period bef...
Many patients with interstitial lung disease (ILD) develop pulmonary fibrosis, which can lead to red...
AbstractBackgroundIdiopathic pulmonary fibrosis (IPF) may be complicated by episodes of acute exacer...
Acknowledgments The authors would like to extend their acknowledgement to Dr Dermot Ryan for his cli...
RATIONALE: The level diagnostic likelihood at which physicians prescribe antifibrotic therapy withou...